| Antibody therapy of cancer AM Scott, JD Wolchok, LJ Old Nature reviews cancer 12 (4), 278-287, 2012 | 2598 | 2012 |
| Comparison of ultracentrifugation, density gradient separation, and immunoaffinity capture methods for isolating human colon cancer cell line LIM1863-derived exosomes BJ Tauro, DW Greening, RA Mathias, H Ji, S Mathivanan, AM Scott, ... Methods 56 (2), 293-304, 2012 | 1252 | 2012 |
| Monoclonal antibodies in cancer therapy AM Scott, JP Allison, JD Wolchok Cancer immunity 12 (1), 2012 | 642 | 2012 |
| [177Lu] Lu-PSMA-617 versus cabazitaxel in patients with metastatic castration-resistant prostate cancer (TheraP): a randomised, open-label, phase 2 trial MS Hofman, L Emmett, S Sandhu, A Iravani, AM Joshua, JC Goh, ... The Lancet 397 (10276), 797-804, 2021 | 620 | 2021 |
| Recombinant NY-ESO-1 protein with ISCOMATRIX adjuvant induces broad integrated antibody and CD4+ and CD8+ T cell responses in humans ID Davis, W Chen, H Jackson, P Parente, M Shackleton, W Hopkins, ... Proceedings of the National Academy of Sciences 101 (29), 10697-10702, 2004 | 538 | 2004 |
| Persistence and efficacy of second generation CAR T cell against the LeY antigen in acute myeloid leukemia DS Ritchie, PJ Neeson, A Khot, S Peinert, T Tai, K Tainton, K Chen, ... Molecular Therapy 21 (11), 2122-2129, 2013 | 489 | 2013 |
| A Phase I dose-escalation study of sibrotuzumab in patients with advanced or metastatic fibroblast activation protein-positive cancer AM Scott, G Wiseman, S Welt, A Adjei, FT Lee, W Hopkins, CR Divgi, ... Clinical cancer research 9 (5), 1639-1647, 2003 | 478 | 2003 |
| The impact of 68Ga-PSMA PET/CT on management intent in prostate cancer: results of an Australian prospective multicenter study PJ Roach, R Francis, L Emmett, E Hsiao, A Kneebone, G Hruby, T Eade, ... Journal of Nuclear Medicine 59 (1), 82-88, 2018 | 369 | 2018 |
| Bridging bio–nano science and cancer nanomedicine M Bjornmalm, KJ Thurecht, M Michael, AM Scott, F Caruso ACS nano 11 (10), 9594-9613, 2017 | 364 | 2017 |
| Hypoxia positron emission tomography imaging with 18F-fluoromisonidazole ST Lee, AM Scott Seminars in nuclear medicine 37 (6), 451-461, 2007 | 337 | 2007 |
| Antibody targeting in metastatic colon cancer: a phase I study of monoclonal antibody F19 against a cell-surface protein of reactive tumor stromal fibroblasts. S Welt, CR Divgi, AM Scott, P Garin-Chesa, RD Finn, M Graham, ... Journal of clinical oncology 12 (6), 1193-1203, 1994 | 312 | 1994 |
| A phase I clinical trial with monoclonal antibody ch806 targeting transitional state and mutant epidermal growth factor receptors AM Scott, FT Lee, N Tebbutt, R Herbertson, SS Gill, Z Liu, E Skrinos, ... Proceedings of the National Academy of Sciences 104 (10), 4071-4076, 2007 | 305 | 2007 |
| Growth suppression of intracranial xenografted glioblastomas overexpressing mutant epidermal growth factor receptors by systemic administration of monoclonal antibody (mAb) 806 … K Mishima, TG Johns, RB Luwor, AM Scott, E Stockert, AA Jungbluth, ... Cancer research 61 (14), 5349-5354, 2001 | 264 | 2001 |
| A monoclonal antibody recognizing human cancers with amplification/overexpression of the human epidermal growth factor receptor AA Jungbluth, E Stockert, HJS Huang, VP Collins, K Coplan, K Iversen, ... Proceedings of the National Academy of Sciences 100 (2), 639-644, 2003 | 261 | 2003 |
| Clinical role of F-18 fluorodeoxyglucose positron emission tomography for detection and management of renal cell carcinoma S RAMDAVE, GW THOMAS, SU Berlangieri, DM Bolton, IAN DAVIS, ... The Journal of urology 166 (3), 825-830, 2001 | 256 | 2001 |
| Construction and characterisation of a functional CD19 specific single chain Fv fragment for immunotherapy of B lineage leukaemia and lymphoma IC Nicholson, KA Lenton, DJ Little, T Decorso, FT Lee, AM Scott, H Zola, ... Molecular immunology 34 (16-17), 1157-1165, 1997 | 253 | 1997 |
| The human A33 antigen is a transmembrane glycoprotein and a novel member of the immunoglobulin superfamily JK Heath, SJ White, CN Johnstone, B Catimel, RJ Simpson, RL Moritz, ... Proceedings of the National Academy of Sciences 94 (2), 469-474, 1997 | 252 | 1997 |
| Antibody–drug conjugates for cancer therapy U Hafeez, S Parakh, HK Gan, AM Scott Molecules 25 (20), 4764, 2020 | 249 | 2020 |
| Correlation of hypoxic cell fraction and angiogenesis with glucose metabolic rate in gliomas using 18F-fluoromisonidazole, 18F-FDG PET, and immunohistochemical studies LM Cher, C Murone, N Lawrentschuk, S Ramdave, A Papenfuss, ... Journal of Nuclear Medicine 47 (3), 410-418, 2006 | 242 | 2006 |
| The contribution of 18F-fluoro-2-deoxy-glucose positron emission tomographic imaging to radiotherapy planning in lung cancer JD Kiffer, SU Berlangieri, AM Scott, G Quong, M Feigen, W Schumer, ... Lung cancer 19 (3), 167-177, 1998 | 238 | 1998 |
